Accurate Background’s Post

🌿 Navigating Cannabis Compliance: Join Our Webinar! 🌿 Staying compliant with the ever-changing landscape of cannabis legalization can be a challenge for employers. Our upcoming webinar will address key areas of concern, including: 🔍 An in-depth review of existing state and local medical/recreational cannabis laws and their impact on employer protections. 📋 A comprehensive analysis of 2023 drug testing considerations, including relevant state policy requirements. 🚦 Specific considerations for employers subject to regulations, such as those imposed by the Department of Transportation (DOT) and government contracts. ❓ A dedicated Q&A session to address your specific questions. 🗓️ Date: July 17th 🕙 Time: 10:00 AM PT / 1:00 PM ET Register today and stay ahead of the compliance curve! 🚀 #CannabisCompliance #Webinar #EmployerGuidance #DrugTesting #HRCompliance #DOTRegulations

Cannabis in the United States FDA waits 5 years then punts. U.S. Department of Health and Human Services (HHS) maybe recommends rescheduling to III. (still today no one can produce the letter). Now, 14 Republicans from US Congress write a letter to the Drug Enforcement Administration urging them not to reschedule cannabis. Taken directly from the letter… “Any decision to reschedule cannabis, should be based on proven facts and science—not popular opinion, changes in state laws, or the preferred policy of an administration. “It is irresponsible for HHS to recommend that marijuana be removed from Schedule I. It would also be irresponsible for DEA to act on this recommendation,” the letter concludes. “Our country relies on DEA to enforce our nation’s drug laws. We ask you to uphold your mission by rejecting any effort to remove marijuana from Schedule I.” In typical fashion, the letter cites outdated facts long since disproven and demands more research and data- which they won’t bother to read. To say nothing has changed related to cannabis since 2016 is laughable. Is there any US government agency or representative who still listens to the will of the American people? Links to Marijuana Moment article, the letter from #congress, and Beard Bros article about the last time DEA was involved in rescheduling all in the comments. #FOCUS #cannabis #hemp #CARE #regulations #schedule1 #deschedulenotreschedule #weneedbetterleaders #publichealth #safetyfirst #heretohelp

While the DEA's alignment with the Department of Health and Human Services' recommendation to move cannabis to Schedule III from Schedule I has been recognized as significant, the full implications of this move are still uncertain, and it does not legalize cannabis under federal law. Jonathan Havens 🟦, Cannabis Law practice co-chair at Saul Ewing LLP, told Cannabis Business Times that despite the limitations of rescheduling and the work ahead, it’s important to keep this in context and remember—this is a very big deal. “The headline to me is the federal government is poised to make the most significant controlled substances reform since really the enactment of the Controlled Substance Act,” Havens said of the 50-plus-year-old law. “To have a president say that federal agencies must expeditiously evaluate the appropriate scheduling of marijuana … President Biden issued his executive order less than two years ago … and to have HHS issue its findings less than a year later .... By Washington standards, that's lightning quick, particularly with something as like marijuana policy, which has essentially been the same for 50-plus years.” To read the full article, visit: https://lnkd.in/eyte7J6v #Cannabis #Rescheduling #DEA #CannabisPolicy

Confused by cannabis laws impacting your business? Our July 17th webinar cuts through the haze. Gain clarity from Seyfarth Shaw's expert & learn actionable strategies for compliant hiring & drug testing. Register now & secure your spot!

📢 Exciting news in the world of cannabis legislation! 🌿 🔥 The U.S. Department of Health and Human Services (HHS) has just issued a groundbreaking letter to the Drug Enforcement Administration (DEA), recommending the rescheduling of cannabis to Schedule III. 🔥 This move could have far-reaching implications for the medical and legal cannabis industries, opening up new avenues for research, development, and patient access. ✅ #HHS #DEA #CannabisRescheduling #ScheduleIII #MedicalCannabis #Legalization Stay tuned for more updates on this historic recommendation! Together, we can advance the conversation and unlock the potential of cannabis for a healthier future. 💚 #collateralbasefirm #cannabisindustry #cannabisnews #cannabisadvocacy

The Rescheduling of Cannabis: Government Scientists Speak - Will DEA Listen? was just published in the latest edition of "The Health Lawyer," an American Bar Association publication. In the article, my law partner Gui Ferrari Faviero, Esq., MS, MPH and I explain the meaning and consequences of the rescheduling cannabis to Schedule III from the perspective of two seasoned FDA regulatory attorneys who also practice in the cannabis regulatory space. Reach out to us if you require FDA or Cannabis regulatory advice. Link to the article is in the comments. #cannabislaw #cannabisbusiness #fdaregulations #fdacompliance #DEAschedule3 #marijuana

Legislation is pending, Senate Bill 363, to amend the state’s traffic safety laws so that they no longer discriminate against medical cannabis patients. The state’s current zero tolerance law makes it a crime for any person to operate a motor vehicle with any detectable level of either THC or its metabolites in their blood – even absent any evidence of driver impairment. Over 900,000 Pennsylvanians are registered to use medical cannabis products. The imposition of this zero-tolerance standard places each of them at risk of arrest every time they drive a car. Change PA Traffic Safety Laws To Stop Discriminating Against Medical Cannabis Patients SB 363 requires police to have evidence of driving impairment prior to making a DUI cannabis arrest. This is the same standard that applies to other medications. The sole presence of THC and/or its metabolites in blood, particularly at low levels, is an inconsistent and inappropriate indicator of psychomotor impairment. It’s time to change this standard and stop discriminating against medical cannabis patients. https://lnkd.in/e9X5GX3B

On This #MedicalMonday: Empowerment through Education, Part IV: Medical Cannabis Grow Laws and Cultivation Here, Cannabis Patients Pacific Northwest co-founders Jeremy Robbins and David Benedicktus provide insights into the #medicalcannabis laws, taxes, and other obstacles patients in the Pacific Northwest must navigate to access their medication, plus the challenges and rewards of methods of at-home #cannabiscultivation. ➡️ Join us as we dive into the complexities of cannabis laws and regulations: https://ow.ly/uJK450Qr1ti

🚨 Cannabis Legalization Update! 🌿💼 🔐 Trigger Laws: What You Need to Know 🔐 Hey #LinkedIn community! Today, let's dive into the intriguing world of trigger laws and how they impact cannabis legalization. 💡💼 🌐 In a captivating video, Tom Howard, a renowned cannabis lawyer, breaks down the nitty-gritty of trigger laws and their implications for state-level drug scheduling. Let's unpack the key takeaways, shall we? 📝🔍 📌 Trigger laws are legal mechanisms that states use to respond to changes in federal drug scheduling. Essentially, when the federal government alters the schedule of a substance, these laws determine how states should adjust their own drug schedules accordingly. 📜💼 ✅ Some states have adopted the Uniform Controlled Substances Act (CSA), an automatic rescheduling mechanism. This means that if the federal government changes the schedule of a substance, these states will swiftly update their schedules to align with federal law. Talk about staying in sync! 🔄📆 ❗️ On the other hand, some states still operate under the original CSA from 1970. For these states, drug scheduling changes require a thorough review and recommendation from the state agency or legislature. It's a more involved process, but it ensures careful deliberation and consideration. 🧐💬 🔀 Lastly, there are states with trigger laws that grant the agency the power to reschedule substances. However, the legislature retains the authority to override the agency's decision. It's like a checks-and-balances system for drug scheduling! ⚖️✍️ 🔮 Looking ahead, Howard suggests that the process of rescheduling cannabis will likely involve an interim rule, a public comment period, and potential litigation. Brace yourselves for a fascinating journey through legal procedures! ⏳⚖️ 🔍 So, whether you're a cannabis entrepreneur, legal professional, or simply curious about the evolving landscape of drug policy, this video is a must-watch! Get informed and stay ahead of the curve. 📺🌿🔍 👉 Check out the video and let's spark a dynamic conversation in the comments below! 💬🔥 https://lnkd.in/g9pZi6pc #CannabisLegalization #TriggerLaws #DrugPolicy #LegalInsights #StayInformed

Some thoughts on last week's big news in the Cannabis Community 🌿 . . . The U.S. Drug Enforcement Administration (DEA) made a groundbreaking announcement, and will move cannabis from a Schedule 1 to a Schedule 3 substance under the Controlled Substances Act. This shift is monumental, and here’s why it’s a positive step forward, despite some criticisms within the community. Firstly, it’s essential to acknowledge what the rescheduling represents: an admission that previous policies regarding cannabis were misguided. For over 50 years, cannabis was classified alongside substances with "no currently accepted medical use and a high potential for abuse." This reclassification to Schedule 3, which includes drugs that have a potential for abuse less than Schedule 1 and 2 drugs but more than Schedule 4, acknowledges cannabis's medical benefits and lower potential for abuse. While some argue that this move primarily benefits large corporate entities in cannabis, it’s crucial to recognize the broader impacts: Research Opportunities - Moving to Schedule 3 significantly eases restrictions on research, allowing for more comprehensive studies on cannabis’s benefits and risks. Banking and Business - This reclassification should alleviate some of the banking issues that cannabis businesses face, opening up more traditional banking opportunities less burdened by federal regulations. Legal Protections - It offers greater legal protections to consumers and businesses involved with cannabis, moving away from the severe penalties associated with Schedule 1 substances. It’s true that rescheduling is not the same as full decriminalization, which would eliminate federal penalties altogether. However, full decriminalization requires congressional action and presidential approval, a lengthy and uncertain process. Alternatively, rescheduling is a significant, achievable step that can occur more swiftly and still brings substantial benefits. Let's not understate the importance of this development. It's a significant acknowledgment of past errors in cannabis policy and a substantial step toward rational drug laws. Change often happens incrementally, and this is a pivotal shift that can lead to more comprehensive reforms in the future. You can hear more of my thoughts on this and other news and events that will impact cannaseurs on the Cannabis Man Podcast, available everywhere. #CannabisReform #DEARescheduling #CannabisCommunity #DrugPolicyReform